RT Journal Article
SR Electronic
T1 Deconvoluting complex correlates of COVID19 severity with local ancestry inference and viral phylodynamics: Results of a multiomic pandemic tracking strategy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.04.21261547
DO 10.1101/2021.08.04.21261547
A1 Victoria N. Parikh
A1 Alexander G. Ioannidis
A1 David Jimenez-Morales
A1 John E. Gorzynski
A1 Hannah N. De Jong
A1 Xiran Liu
A1 Jonasel Roque
A1 Victoria P. Cepeda-Espinoza
A1 Kazutoyo Osoegawa
A1 Chris Hughes
A1 Shirley C. Sutton
A1 Nathan Youlton
A1 Ruchi Joshi
A1 David Amar
A1 Yosuke Tanigawa
A1 Douglas Russo
A1 Justin Wong
A1 Jessie T. Lauzon
A1 Jacob Edelson
A1 Daniel Mas Montserrat
A1 Yongchan Kwon
A1 Simone Rubinacci
A1 Olivier Delaneau
A1 Lorenzo Cappello
A1 Jaehee Kim
A1 Massa J. Shoura
A1 Archana N. Raja
A1 Nathaniel Watson
A1 Nathan Hammond
A1 Elizabeth Spiteri
A1 Kalyan C. Mallempati
A1 Gonzalo Montero-Martín
A1 Jeffrey Christle
A1 Jennifer Kim
A1 Anna Kirillova
A1 Kinya Seo
A1 Yong Huang
A1 Chunli Zhao
A1 Sonia Moreno-Grau
A1 Steven G. Hershman
A1 Karen P. Dalton
A1 Jimmy Zhen
A1 Jack Kamm
A1 Karan D. Bhatt
A1 Alina Isakova
A1 Maurizio Morri
A1 Thanmayi Ranganath
A1 Catherine A. Blish
A1 Angela J. Rogers
A1 Kari Nadeau
A1 Samuel Yang
A1 Andra Blomkalns
A1 Ruth O’Hara
A1 Norma F. Neff
A1 Christopher DeBoever
A1 Sándor Szalma
A1 Matthew T. Wheeler
A1 Kyle Farh
A1 Gary P. Schroth
A1 Phil Febbo
A1 Francis deSouza
A1 Marcelo Fernandez-Vina
A1 Amy Kistler
A1 Julia Palacios
A1 Benjamin A. Pinsky
A1 Carlos D. Bustamante
A1 Manuel A Rivas
A1 Euan A. Ashley
YR 2021
UL http://medrxiv.org/content/early/2021/08/08/2021.08.04.21261547.abstract
AB The SARS-CoV-2 pandemic has differentially impacted populations of varied race, ethnicity and socioeconomic status. Admixture mapping and local ancestry inference represent powerful tools to examine genetic risk within multi-ancestry genomes independent of these confounding social constructs. Here, we leverage a pandemic tracking strategy in which we sequence viral and host genomes and transcriptomes from 1,327 nasopharyngeal swab residuals and integrate them with digital phenotypes from electronic health records. We demonstrate over-representation of individuals possessing Oceanian and Indigenous American ancestry in SARS-CoV-2 positive populations. Genome-wide-association disaggregated by admixture mapping reveals regions of chromosomes 5 and 14 associated with COVID19 severity within African and Oceanic local ancestries, respectively, independent of overall ancestry fraction. Phylodynamic tracking of consensus viral genomes reveals no association with disease severity or inferred ancestry. We further present summary data from a multi-omic investigation of human-leukocyte-antigen (HLA) typing, nasopharyngeal microbiome and human transcriptomics that reveal metagenomic and HLA associations with severe COVID19 infection. This work demonstrates the power of multi-omic pandemic tracking and genomic analyses to reveal distinct epidemiologic, genetic and biological associations for those at the highest risk.Competing Interest StatementVNP is a consultant and scientific advisor for Biomarin. CAB is on the SAB of Catamaran Bio and DeepCell, Inc. AJR is a Scientific Advisor of Merck, MTW is a stockholder of Personalis, Inc., GPS is on the SAB of Jumpcode Genomics. CDB is a member of the scientific advisory boards for Liberty Biosecurity, Personalis, 23andMe Roots into the Future, Ancestry.com, IdentifyGenomics, Genomelink, and Etalon and is a founder of CDB Consulting. MAR is on the SAB of 54Gene, Related Sciences and scientific founder of Broadwing Bio and has advised BioMarin, Third Rock Ventures and MazeTx. EAA is a founder of Personalis, Inc and DeepCell, Inc, a founding advisor of Neuvocor, a non-executive director at AstraZeneca, and an advisor of GenomeMedical, Novartis, Medical Excellence Capital, Foresite Capital, Cathay Capital and Third Rock Ventures.Funding StatementNHLBI K08HL143185 (VNP), NIH R01HL144843 (EAA), NIH R01GM121404 (JAP), NIH U01HG009080 (MAR, AGI), (MAR), NIH U24 OD026629 04S1 (EAA, MTW), Stanford Medicine Deans Postdoctoral Fellowship, American Heart Association Postdoctoral Fellowship, & Arnold O. Beckman Postdoctoral Independence Award (MJS), the John Taylor Babbitt Foundation (VNP), and the Sarnoff Cardiovascular Research Foundation (VNP), the Chan Zuckerberg Biohub, OneLambda, Thermofisher, Illumina, Inc., and Takeda Development Center Americas, Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford University School of Medicine Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have established a resource of summary statistics for COVID19 severity versus host genotype by genetic ancestry, host HLA type, and metagenomic alignments (SEE LINK BELOW), and have contributed host genetic summary data and viral consensus sequences to the COVID19 Host Genetics Initiative(1) and GISAID (GISAID.org,2) respectively. (1) Initiative, C.19 H. G. & COVID19 Host Genetics Initiative. Mapping the human genetic architecture of COVID19. Nature (2021) (2) Elbe, S. & BucklandMerrett, G. Data, disease and diplomacy: GISAIDs innovative contribution to global health. Glob Chall 1,(2017). https://covid-omics.org/results